Abciximab
Top View
- Medication Safety and High Alert Medications Objectives
- Summary of Product Characteristics
- Reopro Abciximab for Intravenous Administration
- Pharmaceutical Compositions Comprising Prasugrel And
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Antithrombotic Effects of Abciximab
- Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing
- Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
- ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
- Effect of Low-Dose Intracoronary Alteplase During Primary
- In Situ Administration of Abciximab for Thrombus Resolution During Intracranial Bypass Surgery: Case Report
- Annex I Summary of Product Characteristics
- Xigris, INN-Drotrecogin Alfa
- 2020 Table of Drugs
- The Effect of Enoxaparin on in Vitro Stimulated Platelet Aggregation by Elective Percutaneous Coronary Intervention Patients
- Occurrence and Clinical Significance of Pseudothrombocytopenia During
- Appendix C - Guidelines for IV Medication Administration